Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johan Karlsson

Showing results (71-80 of 78) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 78 results.
Journal of Medicinal Chemistry|June 1, 2018
Discovery of Highly Isoform Selective Orally Bioavailable Phosphoinositide 3-Kinase (PI3K)-γ InhibitorsNils Pemberton, Mickael Mogemark, Susanne Arlbrandt, et al.
The Lancet. Planetary Health|March 7, 2024
Environmental assessment of diets: overview and guidance on indicator choiceYlva Ran, Christel Cederberg, Malin Jonell, et al.
Annals of the Rheumatic Diseases|April 9, 2021
EULAR Points to Consider (PtC) for designing, analysing and reporting of studies with work participation as an outcome domain in patients with inflammatory arthritisAnnelies Boonen, Polina Putrik, Mary Lucy Marques, et al.
Rheumatology (Oxford, England)|September 22, 2023
Second and third TNF inhibitors in European patients with axial spondyloarthritis: effectiveness and impact of the reason for switchingLouise Linde, Lykke Midtbøll Ørnbjerg, Cecilie Heegaard Brahe, et al.
BMC Medical Research Methodology|February 28, 2025
Handling of missing component information for common composite score outcomes used in axial spondyloarthritis research when complete-case analysis is unbiasedChristos Polysopoulos, Stylianos Georgiadis, Lykke Midtbøll Ørnbjerg, et al.
The Lancet Regional Health. Europe|August 21, 2023
Differences and similarities between the EULAR/ASAS-EULAR and national recommendations for treatment of patients with psoriatic arthritis and axial spondyloarthritis across EuropeBrigitte Michelsen, Mikkel Østergaard, Michael John Nissen, et al.
Health Policy (Amsterdam, Netherlands)|April 17, 2025
Disparities in the organisation of national healthcare systems for treatment of patients with psoriatic arthritis and axial spondyloarthritis across EuropeBrigitte Michelsen, Mikkel Østergaard, Michael John Nissen, et al.
Briefings in Bioinformatics|February 2, 2008
Interoperability with Moby 1.0--it's better than sharing your toothbrush!, Mark D Wilkinson, Martin Senger, et al.
Pageof 8

Showing results (71-80 of 78) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 78 results.
Journal of Medicinal Chemistry|June 1, 2018
Discovery of Highly Isoform Selective Orally Bioavailable Phosphoinositide 3-Kinase (PI3K)-γ InhibitorsNils Pemberton, Mickael Mogemark, Susanne Arlbrandt, et al.
The Lancet. Planetary Health|March 7, 2024
Environmental assessment of diets: overview and guidance on indicator choiceYlva Ran, Christel Cederberg, Malin Jonell, et al.
Annals of the Rheumatic Diseases|April 9, 2021
EULAR Points to Consider (PtC) for designing, analysing and reporting of studies with work participation as an outcome domain in patients with inflammatory arthritisAnnelies Boonen, Polina Putrik, Mary Lucy Marques, et al.
Rheumatology (Oxford, England)|September 22, 2023
Second and third TNF inhibitors in European patients with axial spondyloarthritis: effectiveness and impact of the reason for switchingLouise Linde, Lykke Midtbøll Ørnbjerg, Cecilie Heegaard Brahe, et al.
BMC Medical Research Methodology|February 28, 2025
Handling of missing component information for common composite score outcomes used in axial spondyloarthritis research when complete-case analysis is unbiasedChristos Polysopoulos, Stylianos Georgiadis, Lykke Midtbøll Ørnbjerg, et al.
The Lancet Regional Health. Europe|August 21, 2023
Differences and similarities between the EULAR/ASAS-EULAR and national recommendations for treatment of patients with psoriatic arthritis and axial spondyloarthritis across EuropeBrigitte Michelsen, Mikkel Østergaard, Michael John Nissen, et al.
Health Policy (Amsterdam, Netherlands)|April 17, 2025
Disparities in the organisation of national healthcare systems for treatment of patients with psoriatic arthritis and axial spondyloarthritis across EuropeBrigitte Michelsen, Mikkel Østergaard, Michael John Nissen, et al.
Briefings in Bioinformatics|February 2, 2008
Interoperability with Moby 1.0--it's better than sharing your toothbrush!, Mark D Wilkinson, Martin Senger, et al.
Pageof 8